Muhammad Aasim Ali: Treatment Strategies for Chemotherapy-Induced Cytopenias
Muhammad Aasim Ali, Pharmacist at Premium Care Medical Polyclinic, shared a post on LinkedIn:
”Cancer Myelosuppression Treatment
Cancer therapy–induced myelosuppression:
Neutropenia:
Granulocyte colony-stimulating factors include:
- filgrastim
- pegfilgrastim
They act on myeloid progenitors via the G-CSF receptor to accelerate neutrophil proliferation, differentiation, and release from the bone marrow.
Pegylation prolongs half-life and allows once-per-cycle dosing.
These agents reduce febrile neutropenia risk but can cause bone pain and, rarely, splenic complications.
Anemia:
Chemotherapy-induced anemia is addressed with erythropoiesis-stimulating agents such as:
- epoetin alfa
- darbepoetin alfa
These drugs activate erythropoietin receptors on erythroid progenitors to increase erythrocyte production.
However, their use is restricted due to risks of thromboembolism and potential tumor progression, and they are generally reserved for palliative settings with careful hemoglobin targets.
Thrombocytopenia:
- Oprelvekin: a recombinant human IL-11 drug used to prevent severe thrombocytopenia and reduce the need for platelet transfusions.
It acts as a thrombopoietic growth factor that stimulates the bone marrow to produce more megakaryocytes and platelets.”
Stay updated with Hemostasis Today.
-
Jun 6, 2026, 13:01Kathleen Freson: αIIbβ3’s Hidden Role in Platelet Production
-
Jun 6, 2026, 12:22Jonas Kingo: Factor XI at the Crossroads of Hormonal Regulation and Thrombosis at ISTH 2026
-
Jun 6, 2026, 12:06Reza Shojaei: Why Dried Plasma May Be the Most Important Plasma Innovation in Decades
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis